Glasgow Times on MSN16h
Drug combination nearly erases liver cancer in major breakthrough
A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug ...
EurekAlert!2d
Unraveling the role of the Wnt pathway in hepatocellular carcinoma: From molecular mechanisms to therapeutic implications
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
Morningstar8d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lenvatinib, a well-established first-line treatment for advanced hepatocellular carcinoma, demonstrates the ability to reprogram the immunosuppressive tumour microenvironment into an immune ...
pulmonologyadvisor6d
Mixed Results for Pembrolizumab/Lenvatinib in Advanced Gastroesophageal Cancer Trial
Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.
emjreviews.com6d
Clinical Complete Response a New Prognostic Marker in Liver Cancer
CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...
Cure Today26d
Opdivo Plus Yervoy May Improve Survival and Responses in Frontline uHCC
Among patients with unresectable hepatocellular carcinoma (uHCC), the combination of Opdivo ... Yervoy showed a significant improvement in median OS compared with Lenvima (lenvatinib) or Nexavar ...
Taiwan News8d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...